{"type":"trials","record":{"id":35376,"source_id":"clinicaltrials-gov","external_id":"NCT05732506","title":"Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria","brief_summary":"The aim of the present study is to prospectively evaluate the safety of Edoxaban.","overall_status":"Completed","phases":[],"study_type":"OBSERVATIONAL","sponsor":"Galaxia Empírica","enrollment":411,"countries":["Spain"],"start_date":"2023-02-01","completion_date":"2025-04-09","last_update_date":"2025-04-11","source_url":"https://clinicaltrials.gov/study/NCT05732506","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:20:20.087268+00:00","last_seen_at":"2026-09-25T06:10:07.378+00:00","metadata":{"sex":"ALL","acronym":null,"age_range":"75 Years","comparator":null,"organization":"Galaxia Empírica","interventions":["Edoxaban"],"registry_source":"ClinicalTrials.gov","outcome_measures":["Major bleeding. — 12 months","Stroke or systemic embolism. — 12 months"],"design_description":null,"source_has_results":false},"controlled_terms":["Auricular Fibrillation","Edoxaban"],"relevance_confidence":80,"source_quality_score":100,"freshness_score":65,"publication_state":"published","match_explanation":"Title contains controlled term: frailty.","quality_checked_at":"2026-09-25T06:10:20.034853+00:00","duplicate_cluster_key":"id:nct05732506","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2023-02-01 to 2025-04-09","comparator":null,"confidence":"structured-source","population":"ALL · 75 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:10:07.515Z","intervention":["Edoxaban"],"participants":411,"study_design":"OBSERVATIONAL","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Major bleeding. — 12 months","Stroke or systemic embolism. — 12 months"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"frailty","is_published":true,"match_reasons":["Title contains controlled term: frailty.","Title supplies longevity context: frailty, frail.","Study type is explicitly identified as OBSERVATIONAL."],"matched_fields":["title","title context","study type"],"relevance_score":80,"intelligence_topics":{"name":"Frailty","slug":"frailty"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/35376","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}